Segueix
Almudena Bosch
Almudena Bosch
Correu electrònic verificat a mssm.edu
Títol
Citada per
Citada per
Any
NR2F1 controls tumour cell dormancy via SOX9-and RARβ-driven quiescence programmes
MS Sosa, F Parikh, AG Maia, Y Estrada, A Bosch, P Bragado, E Ekpin, ...
Nature communications 6 (1), 6170, 2015
3372015
Cbx8 acts non-canonically with Wdr5 to promote mammary tumorigenesis
CY Chung, Z Sun, G Mullokandov, A Bosch, ZA Qadeer, E Cihan, Z Rapp, ...
Cell reports 16 (2), 472-486, 2016
1072016
The epigenetic regulators Bmi1 and Ring1B are differentially regulated in pancreatitis and pancreatic ductal adenocarcinoma
C Martínez‐Romero, I Rooman, A Skoudy, C Guerra, X Molero, ...
The Journal of Pathology: A Journal of the Pathological Society of Great …, 2009
672009
Reversal by RARα agonist Am580 of c-Myc-induced imbalance in RARα/RARγ expression during MMTV-Myc tumorigenesis
A Bosch, SP Bertran, Y Lu, A Garcia, AM Jones, MI Dawson, EF Farias
Breast cancer research 14, 1-19, 2012
492012
CRISPRi screens reveal a DNA methylation-mediated 3D genome dependent causal mechanism in prostate cancer
M Ahmed, F Soares, JH Xia, Y Yang, J Li, H Guo, P Su, Y Tian, HJ Lee, ...
Nature communications 12 (1), 1781, 2021
432021
The Polycomb group protein RING1B is overexpressed in ductal breast carcinoma and is required to sustain FAK steady state levels in breast cancer epithelial cells
A Bosch, K Panoutsopoulou, JM Corominas, R Gimeno, G Moreno-Bueno, ...
Oncotarget 5 (8), 2065, 2014
392014
Histone H3 lysine 27 crotonylation mediates gene transcriptional repression in chromatin
N Liu, T Konuma, R Sharma, D Wang, N Zhao, L Cao, Y Ju, D Liu, ...
Molecular Cell 83 (13), 2206-2221. e11, 2023
332023
NR2F1 controls tumour cell dormancy via SOX9-and RARbeta-driven quiescence programmes. Nat Commun 6: 6170
MS Sosa, F Parikh, AG Maia, Y Estrada, A Bosch, P Bragado, E Ekpin, ...
Acknowledgment, 2015
122015
Blocking the PAH2 domain of Sin3A inhibits tumorigenesis and confers retinoid sensitivity in triple negative breast cancer
N Bansal, A Bosch, B Leibovitch, L Pereira, E Cubedo, J Yu, ...
Oncotarget 7 (28), 43689, 2016
112016
NR2F1 controls tumour cell dormancy via SOX9-and RARβ-driven quiescence programmes. Nat Commun. 2015; 6: 6170
MS Sosa, F Parikh, AG Maia, Y Estrada, A Bosch, P Bragado, E Ekpin, ...
7
Dysfunction of ubiquitin protein ligase MYCBP2 leads to cell resilience in human breast cancers
RA Neff, A Bosch-Gutierrez, Y Sun, I Katsyv, W Song, M Wang, MJ Walsh, ...
NAR cancer 5 (3), zcad036, 2023
12023
Targeted epigenetic reprogramming reverts tumor progression in triple-negative breast cancer models by the activation of retinoic acid receptor alpha
N Bansal, A Bosch, BA Leibovitch, K Pierzchalski, Z Ming-Ming, M Kane, ...
Cancer Research 75 (15_Supplement), 3511-3511, 2015
2015
NR2F1 controls tumor cell fate via SOX9 and RAR beta driven quiescence and pluripotency programs
MS Sosa, Y Estrada, F Parikh, A Bosch, Y Zheng, P Bragado, E Ekpin, ...
CLINICAL & EXPERIMENTAL METASTASIS 32 (3), 240-240, 2015
2015
Abstract A021: Loss-of-function screen for breast tumor initiating cells reveals PRC1 dependence
CY Chung, A Gaspar-Maia, G Mullokandov, A Bosch-Gutierrez, E Farias, ...
Molecular Cancer Research 11 (10_Supplement), A021-A021, 2013
2013
NR2F1 coordinates a dormancy program by inducing low self-renewal capacity and a repressive chromatin state.
MS Sosa, Y Estrada, F Parikh, AB Gutierrez, Y Zheng, P Bragado, E Ekpin, ...
Cancer Research 73 (8_Supplement), 1090-1090, 2013
2013
NR2F1 and SOX9 mediate reprogramming of tumor cells into dormancy: Potential role in dormant bone marrow DTCs
MS Sosa, Y Estrada, F Parikh, A Bosch-Gutierrez, E Ekpin, A George, ...
Cancer Research 72 (8_Supplement), 4262-4262, 2012
2012
Role of Ring1B in ephitelial to mesenchimal transition, invasion and migration of mammary epithelial cells
A Bosch Gutiérrez
Universitat Pompeu Fabra, 2009
2009
Un caso inusual de carcinoma ductal invasor desarrollado sobre un tumor phyllodes maligno
AL Bosch
En aquests moments el sistema no pot dur a terme l'operació. Torneu-ho a provar més tard.
Articles 1–18